Gene · 239
Papers2,360
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,360
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Elevated ALOX12 in renal tissue predicts progression in diabetic kidney disease. | Ren Fail | 2024 | 38345057 | PubTator, text mining | PubMed |
| Serum metabolism characteristics of patients with myocardial injury after noncardiac surgery explored by the untargeted metabolomics approach. | BMC Cardiovasc Disord | 2024 | 38310264 | PubTator, text mining | PubMed |
| The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. | J Cancer Res Clin Oncol | 2024 | 38279987 | PubTator, text mining | PubMed |
| A novel PCDscore based on programmed cell death-related genes can effectively predict prognosis and therapy responses of colon adenocarcinoma. | Comput Biol Med | 2024 | 38217978 | PubTator, text mining | PubMed |
| Development of novel ALOX15 inhibitors combining dual machine learning filtering and fragment substitution optimisation approaches, molecular docking and dynamic simulation methods. | J Enzyme Inhib Med Chem | 2024 | 38213304 | PubTator, text mining | PubMed |
| The polyol pathway and nuclear ketohexokinase A signaling drive hyperglycemia-induced metastasis of gastric cancer. | Exp Mol Med | 2024 | 38200154 | PubTator, text mining | PubMed |
| Uncovering hidden cancer self-dependencies through analysis of shRNA-level dependency scores. | Sci Rep | 2024 | 38195844 | PubTator, text mining | PubMed |
| Correction: Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma. | Cell Death Dis | 2024 | 38195601 | PubTator, text mining | PubMed |
| The application of approaches in detecting ferroptosis. | Heliyon | 2024 | 38187349 | PubTator, text mining | PubMed |
| Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. | J Cell Mol Med | 2024 | 38140764 | PubTator, text mining | PubMed |
| Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity. | Adv Sci (Weinh) | 2024 | 37984863 | PubTator, text mining | PubMed |
| Zinc finger protein 831 promotes apoptosis and enhances chemosensitivity in breast cancer by acting as a novel transcriptional repressor targeting the STAT3/Bcl2 signaling pathway. | Genes Dis | 2024 | 37588209 | PubTator, text mining | PubMed |
| Hypermethylation of the ALOX12 and CBS promoters in osteoporosis: Potential biomarkers for early diagnosis. | Genes Dis | 2024 | 37588196 | PubTator, text mining | PubMed |
| Metabolism-related gene vaccines and immune infiltration in ovarian cancer: A novel risk score model of machine learning. | J Gene Med | 2024 | 37455244 | PubTator, text mining | PubMed |
| Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills. | Antioxid Redox Signal | 2024 | 37132605 | PubTator, text mining | PubMed |
| Iron accumulation and lipid peroxidation: implication of ferroptosis in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2023 | 38274225 | PubTator, text mining | PubMed |
| Impact of Reperfusion on Plasma Oxylipins in ST-Segment Elevation Myocardial Infarction. | Metabolites | 2023 | 38248822 | PubTator, text mining | PubMed |
| Biomarkers of Affective Dysregulation Associated with In Utero Exposure to EtOH. | Cells | 2023 | 38201206 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-based prognostic model for breast cancer helps to discriminate high/low risk groups and treatment priority. | Front Immunol | 2023 | 38152394 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Ferroptosis and Its Role in Viral Pathogenesis. | Viruses | 2023 | 38140616 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/239/papers?page=6